SEC Form D · filed April 9, 2018
Magenta Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (29)
David Scadden · Cambridge, MADirectorMichael Bonney · Cambridge, MADirectorBruce Booth · Cambridge, MADirectorJason Gardner · Cambridge, MAExec · DirectorBlake Byers · Cambridge, MADirectorAlexis Borisy · Cambridge, MADirectorThomas Daniel · Cambridge, MADirectorAmy Ronneberg · Cambridge, MADirectorErik Mulloy · Edmond, OKDirectorTrevor Francis · Edmond, OKDirectorStable Seed Management, Ltd · London, United KingdomDirectorErik S. Bertsen · London, United KingdomExec · DirectorDevin Agnew · San Antonio, TXDirectorJoseph S. Hardiman · London, United KingdomDirectorPeter Heaps · London, United KingdomDirectorZoran Zdraveski · Cambridge, MAExecJeffrey Albers · Cambridge, MADirectorJohn Davis · Castle Rock, COExecWilliam J. Forrest · Poway, CADirectorGwenne Henricks · Poway, CADirectorRobert Fishman · Poway, CADirectorKeith Rabois · San Francisco, CADirectorBrian Grassadonia · San Francisco, CAExec · DirectorDaniele Perito · San Francisco, CADirectorMarcelo Cortes · San Francisco, CADirectorZoran Zdraveski · Cambridge, MAExecAmy Ronneberg · Cambridge, MADirectorJeffrey Albers · Cambridge, MADirectorJohn Davis · Cambridge, MAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗